TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
MGNX

MacroGenics Inc

Healthcare · Biotechnology

4.10$ +0.2% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Cash Flow

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Cash Flow MGNX
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-69.3% -13.5% -50.4% 9.3% -254.9% -216.5% -114.5% -190.1% -57.2% -136.7% -46.1% -54.2%
3.9% 2.8% 8.8% 4.6% 15.2% 17.5% 12.2% 14.9% 7.8% 16.9% 5.1% 3.7%
6.9% 7.8% 14.1% 9.5% 27.5% 31.6% 21.1% 30.6% 13.5% 32.1% 19.8% 9.6%
6.9% 7.8% 14.1% 9.5% 27.5% 29.2% 21.1% 33.3% 15.3%
0.8% -4.2% -5.7% 7.8% -10.9% -20.8% -14.9% 23.2% -4.0% 93.2% 0.9% -19.0%
7.6% 9.1% 13.1% 18.9% 41.5% 6.9% 6.0% 8.2% 2.4% 3.1% 2.5% 1.3%
-7.6% -150.8% -81.1% 50.1% 94.2% -127.9% -8.0% -48.4% 46.5% -140.0% 100.6% -76.3%
0.0% 0.0% 0.0% 0.0%
0.0% 0.0% 0.0% 0.0% -0.4% 0.0% -2.1% 155.8% 0.7% -0.5%
163.8% 202.6% 2.1% 22.7% 174.6% 193.4% 178.3% 162.3% 1.1% 262.9% 0.6% 46.5%
87.0% 38.3% -129.4% 82.1% 14.0% -151.0% 55.9% -76.2% -9.6% -13.9% 55.2% -84.0%
-76.9% -22.7% -63.6% -9.6% -296.4% -223.4% -120.5% -198.3% -59.6% -139.8% -48.6% -55.5%

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?